Company · CIK 1595353
Galmed Pharmaceuticals Ltd.
| CIK | 1595353 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | L3 |
| Business address | Israel |
| Listed | EOCN (Nasdaq) |
| First annual or quarterly report | 2015-03-31 |
Offerings
9 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-289703 | 2025-08-18 | 2026-09-03 | 5 | |
| 333-282753 | 2024-10-21 | 2025-09-02 | 4 | |
| 333-283241 | 2024-11-14 | 2024-11-21 | 2 | |
| 333-281878 | 2024-08-30 | 2024-09-09 | 2 | |
| 333-272722 | 2023-06-16 | 2023-11-29 | 7 | |
| 333-254766 | 2021-03-26 | 2022-07-01 | 3 | |
| 333-223923 | 2018-03-26 | 2021-02-18 | 8 | |
| 333-203133 | 2015-03-31 | 2017-12-22 | 5 | |
| 333-193792 | 2014-02-06 | 2014-03-13 | 5 |
Filings
42| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-09-03 | EFFECTDeclared effective | 333-289703 | 9999999995-26-002874 |
| 2026-04-01 | EFFECTDeclared effective | 333-289703 | 9999999995-26-001038 |
| 2025-09-02 | EFFECTDeclared effective | 333-289703 | 9999999995-25-002804 |
| 2025-09-02 | EFFECTDeclared effective | 333-282753 | 9999999995-25-002797 |
| 2025-08-21 | EFFECTDeclared effective | 333-289703 | 9999999995-25-002710 |
| 2025-08-18 | F-1Registration filed | 333-289703 | 0001641172-25-024659 |
| 2025-04-08 | EFFECTDeclared effective | 333-282753 | 9999999995-25-001032 |
| 2024-11-21 | EFFECTDeclared effective | 333-283241 | 9999999995-24-003548 |
| 2024-11-14 | F-3Shelf registered | 333-283241 | 0001493152-24-046041 |
| 2024-10-28 | EFFECTDeclared effective | 333-282753 | 9999999995-24-003299 |
| 2024-10-21 | F-1Registration filed | 333-282753 | 0001493152-24-041776 |
| 2024-09-09 | EFFECTDeclared effective | 333-281878 | 9999999995-24-002767 |
| 2024-08-30 | F-1Registration filed | 333-281878 | 0001493152-24-034598 |
| 2023-11-29 | EFFECTDeclared effective | 333-272722 | 9999999995-23-003480 |
| 2023-07-18 | 424B4Final prospectus | 333-272722 | 0001493152-23-024789 |
| 2023-07-14 | EFFECTDeclared effective | 333-272722 | 9999999995-23-002093 |
| 2023-07-13 | F-1/AAmendment | 333-272722 | 0001493152-23-024507 |
| 2023-07-12 | F-1/AAmendment | 333-272722 | 0001493152-23-024354 |
| 2023-06-28 | F-1/AAmendment | 333-272722 | 0001493152-23-022693 |
| 2023-06-16 | F-1Registration filed | 333-272722 | 0001493152-23-021672 |
| 2022-07-01 | 424B5Shelf takedown | 333-254766 | 0001493152-22-018384 |
| 2021-04-01 | EFFECTDeclared effective | 333-254766 | 9999999995-21-001260 |
| 2021-03-26 | F-3Shelf registered | 333-254766 | 0001493152-21-006920 |
| 2021-02-18 | 424B5Shelf takedown | 333-223923 | 0001104659-21-025059 |
| 2021-02-16 | 424B5Shelf takedown | 333-223923 | 0001104659-21-022748 |
| 2020-05-15 | 424B5Shelf takedown | 333-223923 | 0001104659-20-062691 |
| 2018-06-21 | 424B5Shelf takedown | 333-223923 | 0001571049-18-000363 |
| 2018-06-18 | 424B5Shelf takedown | 333-223923 | 0001144204-18-034496 |
| 2018-04-04 | 424B5Shelf takedown | 333-223923 | 0001144204-18-019239 |
| 2018-04-02 | EFFECTDeclared effective | 333-223923 | 9999999995-18-000736 |
| 2018-03-26 | F-3Shelf registered | 333-223923 | 0001144204-18-016920 |
| 2017-12-22 | 424B5Shelf takedown | 333-203133 | 0001144204-17-065093 |
| 2017-08-07 | 424B5Shelf takedown | 333-203133 | 0001144204-17-040690 |
| 2016-06-01 | 424B5Shelf takedown | 333-203133 | 0001144204-16-106018 |
| 2015-07-01 | EFFECTDeclared effective | 333-203133 | 9999999995-15-001788 |
| 2015-03-31 | F-3Shelf registered | 333-203133 | 0001144204-15-020121 |
| 2014-03-13 | 424B4Final prospectus | 333-193792 | 0001144204-14-015358 |
| 2014-03-12 | EFFECTDeclared effective | 333-193792 | 9999999995-14-000644 |
| 2014-03-11 | F-1/AAmendment | 333-193792 | 0001144204-14-014712 |
| 2014-02-28 | F-1/AAmendment | 333-193792 | 0001144204-14-012612 |
| 2014-02-06 | F-1Registration filed | 333-193792 | 0001144204-14-006610 |
| 2013-12-31 | DRSDraft made public | 377-00427 | 0001144204-13-069655 |